EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Blocking Th2 Signaling Pathway Alleviates the Clinical Symptoms and Inflammation in Allergic Conjunctivitis

Zhiyan Tao, Wei Liu, Qin Chen, Libo Zhang, Kaiqin She, Guoqing Zhao, Licong Liang, Xuhong Chen, Yiliu Yang, Qin Song, Fang Lu

Investigative Opthalmology & Visual Science · 2023

DOI: 10.1167/iovs.64.10.30 ↗

At a glance

Journal article in Investigative Opthalmology & Visual Science, 2023. Written by Zhiyan Tao and 10 co-authors. Institution: Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China. Major MEDLINE topics: Conjunctivitis, Allergic. Cited 18 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Purpose

To explore the role of Th2 signaling pathway in allergic conjunctivitis (AC).

Methods

Serum Th2 cytokines IL-4 or IL-13 of patients with AC were detected using the Meso scale discovery assay to verify the correlation of Th2 immunity and AC pathogenesis. Wistar Han rats were intraperitoneally and subcutaneously injected with ovalbumin (OVA) to establish an experimental AC model and the Th2 signaling pathway was blocked by an investigational neutralizing antibody (CM310). Serum IgE and OVA-specific IgE were detected by ELISA. Conjunctivitis inflammation, infiltration of eosinophils, and mast cell degranulation were detected by histological examination. Immortalized human conjunctival epithelial cells, a conjunctival epithelial cell line, and peripheral blood mononuclear cells of patients with AC were used as the target cells to study the impact of IL-4 or IL-13 on AC progression. Finally, a STAT6 reporter gene system was constructed using immortalized human conjunctival epithelial cells to confirm whether the downstream signaling pathway activated by IL-4 or IL-13.

Results

Serum IL-4 or IL-13 were increased in patients with AC versus healthy individuals. In an OVA-induced rat experimental AC model, blocking the Th2 signaling pathway with CM310, an investigational neutralizing antibody, alleviated the conjunctival symptoms, and decreased serum IgE, suppressed infiltration of eosinophils and mast cell degranulation. Further, an in vitro model showed CM310 suppressed the secretion of inflammatory cytokine from both immune cells and epithelial cells in both patients peripheral blood mononuclear cells and cell line.

Conclusions

Blocking Th2 signaling pathway alleviates the clinical symptoms and inflammation in AC.

Subjects

MeSH terms (MEDLINE)

Conjunctivitis, AllergicHumansRatsAnimalsMiceInterleukin-13Interleukin-4Leukocytes, MononuclearRats, WistarInflammationImmunoglobulin ESignal TransductionCytokinesOvalbuminTh2 CellsMice, Inbred BALB CDisease Models, Animal

Substances

Interleukin-13Interleukin-4Immunoglobulin ECytokinesOvalbumin

Authors and institutions

  • Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
  • KeyMed Biosciences Inc, Chengdu, Sichuan Province, China.

Cite

APA

Tao, Z., Liu, W., Chen, Q., Zhang, L., She, K., Zhao, G., Liang, L., Chen, X., Yang, Y., Song, Q., & Lu, F. (2023). Blocking Th2 Signaling Pathway Alleviates the Clinical Symptoms and Inflammation in Allergic Conjunctivitis. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.64.10.30

Vancouver

Tao Z, Liu W, Chen Q, Zhang L, She K, Zhao G, et al. Blocking Th2 Signaling Pathway Alleviates the Clinical Symptoms and Inflammation in Allergic Conjunctivitis. Investigative Opthalmology & Visual Science. 2023. doi:10.1167/iovs.64.10.30

BibTeX
@article{Tao2023,
  author = {Tao, Zhiyan and Liu, Wei and Chen, Qin and Zhang, Libo and She, Kaiqin and Zhao, Guoqing and Liang, Licong and Chen, Xuhong and Yang, Yiliu and Song, Qin and Lu, Fang},
  title = {Blocking Th2 Signaling Pathway Alleviates the Clinical Symptoms and Inflammation in Allergic Conjunctivitis},
  journal = {Investigative Opthalmology & Visual Science},
  year = {2023},
  doi = {10.1167/iovs.64.10.30}
}
Start for free →